Physician

Aimee Soyun Paik, MD

According to 2025 Medicare claims, Aimee Paik, MD (NPI: 1255560967) practices dermatology in the Salinas, CA market, with the plurality of this provider's patient population coming from Monterey, CA. This provider's primary affiliated billing organization is SVMHS CLINICS (NPI: 1093158347; TIN: 352401992) and primary practice location at 93901-3916. Paik is affiliated with the Aledade 91 CA MSSP Basic E (ACO ID: A5193), participating under the MSSP model.

Paik's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 450 traditional Medicare patients, billed 2,139 HCPCS/CPT codes, and received $111,059 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 749 prescription claims across 206 beneficiaries totaling $664,475 in drug costs, led by Taltz Autoinjector (Ixekizumab). Open Payments data shows 32 records totaling $718. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $52,588 to $664,475. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$77K$155K2015 Medicare payment: $154,654 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $112,933 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $31,453 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $66,326 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $78,669 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $64,753 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $97,931 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $105,774 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $87,941 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $111,059 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156703,221$154,654
20165032,824$112,933
2017165587$31,453
20183211,235$66,326
20193801,490$78,669
20203611,165$64,753
20213781,609$97,931
20224481,955$105,774
20233801,629$87,941
20244502,139$111,059

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$332K$664K2015 Drug cost: $52,588 (USD; Tot_Drug_Cst)2016 Drug cost: $110,065 (USD; Tot_Drug_Cst)2017 Drug cost: $32,504 (USD; Tot_Drug_Cst)2018 Drug cost: $82,117 (USD; Tot_Drug_Cst)2019 Drug cost: $168,187 (USD; Tot_Drug_Cst)2020 Drug cost: $376,413 (USD; Tot_Drug_Cst)2021 Drug cost: $394,812 (USD; Tot_Drug_Cst)2022 Drug cost: $487,750 (USD; Tot_Drug_Cst)2023 Drug cost: $514,788 (USD; Tot_Drug_Cst)2024 Drug cost: $664,475 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015196411$52,588
2016159406$110,065
201798215$32,504
2018153365$82,117
2019183506$168,187
2020169571$376,413
2021163448$394,812
2022186588$487,750
2023165513$514,788
2024206749$664,475

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths121152$94
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more235348$93
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more188239$64
17000Destruction of precancer skin growth, 1 growth160206$38
17003Destruction of precancer skin growth, 2-14 growths127763$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Taltz AutoinjectorIxekizumab351,036$245,499
OtezlaApremilast13390$62,966
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc521,759$4,399
KetoconazoleKetoconazole1494,552$3,060
Azelaic AcidAzelaic Acid31955$2,890

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.32$718GENZYME CORPORATION
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Aimee Soyun Paik, MD?

Tedicare shows public-source Medicare data for Aimee Soyun Paik, MD (NPI 1255560967), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aimee Soyun Paik, MD have ACO affiliation data?

Aimee Soyun Paik, MD is shown with ACO affiliation data for Aledade 91 CA MSSP Basic E (MSSP, ACO ID A5193).

What billing organization is linked to Aimee Soyun Paik, MD?

Aimee Soyun Paik, MD is linked to SVMHS CLINICS (billing NPI 1093158347) in the available physician profile data.

Does Aimee Soyun Paik, MD have Open Payments data?

Aimee Soyun Paik, MD has 32 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.